KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Net Margin: 2016-2024

Historic Net Margin for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to -4.18%.

  • Amneal Pharmaceuticals' Net Margin rose 64.00% to 2.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.96%, marking a year-over-year increase of 762.00%. This contributed to the annual value of -4.18% for FY2024, which is 67.00% down from last year.
  • Amneal Pharmaceuticals' Net Margin amounted to -4.18% in FY2024, which was down 19.22% from -3.51% recorded in FY2023.
  • Amneal Pharmaceuticals' Net Margin's 5-year high stood at 4.57% during FY2020, with a 5-year trough of -5.88% in FY2022.
  • In the last 3 years, Amneal Pharmaceuticals' Net Margin had a median value of -4.18% in 2024 and averaged -4.52%.
  • As far as peak fluctuations go, Amneal Pharmaceuticals' Net Margin surged by 2,682bps in 2020, and later crashed by 638bps in 2022.
  • Over the past 5 years, Amneal Pharmaceuticals' Net Margin (Yearly) stood at 4.57% in 2020, then crashed by 406bps to 0.51% in 2021, then crashed by 638bps to -5.88% in 2022, then skyrocketed by 237bps to -3.51% in 2023, then slumped by 67bps to -4.18% in 2024.